Literature DB >> 16343421

Mdm2-mediated pRB downregulation is involved in carcinogenesis in a p53-independent manner.

Seiichi Miwa1, Chiharu Uchida, Kyoko Kitagawa, Takayuki Hattori, Toshiaki Oda, Haruhiko Sugimura, Hideyo Yasuda, Hirotoshi Nakamura, Kingo Chida, Masatoshi Kitagawa.   

Abstract

Mdm2 promotes ubiquitination of the tumor suppressor p53 and can function as an oncogene by largely downregulating p53. Although a p53-independent role of Mdm2 has been reported, the underlying mechanism remains unclear. In the present study, we indicated that Mdm2 is involved in p53-independent carcinogenesis via downregulation of pRB. Expression of pRB showed an apparent inverse correlation with Mdm2 expression in 30 patients with non-small cell lung cancer. There were some cases with the p53 mutations in which a high level of Mdm2 and a low level of pRB were expressed. Mdm2 promoted ubiquitination of pRB in cells without wild-type p53. Furthermore, pRB-mediated G1 arrest in a p53-deficient cell line, SRB1, was significantly enhanced by a mutant Mdm2 that lacks pRB ubiquitination activity. Soft-agar colony formation activity of p53-knockout MEF was increased by wild-type Mdm2 but not mutant Mdm2. These findings suggest that overexpression of Mdm2 can perturb a RB pathway regardless of the p53 gene status, promoting carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16343421     DOI: 10.1016/j.bbrc.2005.11.148

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

1.  Stress-induced isoforms of MDM2 and MDM4 correlate with high-grade disease and an altered splicing network in pediatric rhabdomyosarcoma.

Authors:  Aishwarya G Jacob; Dennis O'Brien; Ravi K Singh; Daniel F Comiskey; Robert M Littleton; Fuad Mohammad; Jordan T Gladman; Maria C Widmann; Selvi C Jeyaraj; Cheryl Bolinger; James R Anderson; Donald A Barkauskas; Kathleen Boris-Lawrie; Dawn S Chandler
Journal:  Neoplasia       Date:  2013-09       Impact factor: 5.715

2.  Aberrant activation of p53 due to loss of MDM2 or MDMX causes early lens dysmorphogenesis.

Authors:  Yiwei Zhang; Xin Zhang; Hua Lu
Journal:  Dev Biol       Date:  2014-09-28       Impact factor: 3.582

3.  A Code of Mono-phosphorylation Modulates the Function of RB.

Authors:  Ioannis Sanidas; Robert Morris; Katerina A Fella; Purva H Rumde; Myriam Boukhali; Eric C Tai; David T Ting; Michael S Lawrence; Wilhelm Haas; Nicholas J Dyson
Journal:  Mol Cell       Date:  2019-01-30       Impact factor: 17.970

4.  Posttranslational modifications of the retinoblastoma tumor suppressor protein as determinants of function.

Authors:  James I Macdonald; Frederick A Dick
Journal:  Genes Cancer       Date:  2012-11

5.  Human oncoprotein MDM2 activates the Akt signaling pathway through an interaction with the repressor element-1 silencing transcription factor conferring a survival advantage to cancer cells.

Authors:  S Singh; M Ramamoorthy; C Vaughan; W A Yeudall; S Deb; S Palit Deb
Journal:  Cell Death Differ       Date:  2012-12-14       Impact factor: 15.828

6.  N-(4-Hydroxyphenyl) retinamide potentiated paclitaxel for cell cycle arrest and apoptosis in glioblastoma C6 and RG2 cells.

Authors:  Rajiv Janardhanan; Jonathan T Butler; Naren L Banik; Swapan K Ray
Journal:  Brain Res       Date:  2009-03-10       Impact factor: 3.252

7.  Mdm2 and tumorigenesis: evolving theories and unsolved mysteries.

Authors:  Emir Senturk; James J Manfredi
Journal:  Genes Cancer       Date:  2012-03

8.  MdmX promotes bipolar mitosis to suppress transformation and tumorigenesis in p53-deficient cells and mice.

Authors:  Zdenka Matijasevic; Heather A Steinman; Kathleen Hoover; Stephen N Jones
Journal:  Mol Cell Biol       Date:  2007-11-26       Impact factor: 4.272

9.  Anchorage-independent growth of pocket protein-deficient murine fibroblasts requires bypass of G2 arrest and can be accomplished by expression of TBX2.

Authors:  Tinke L Vormer; Floris Foijer; Camiel L C Wielders; Hein te Riele
Journal:  Mol Cell Biol       Date:  2008-10-20       Impact factor: 4.272

10.  Role of E3 ubiquitin ligases in lung cancer.

Authors:  Barbara C Snoek; Leonie Ham de Wilt; Gerrit Jansen; Godefridus J Peters
Journal:  World J Clin Oncol       Date:  2013-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.